| 1 |
Ball EE, Weiss CM, Liu H, Jackson K, Keel MK, Miller CJ, Van Rompay KKA, Coffey LL, Pesavento PA. Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model. Am J Pathol 2023:S0002-9440(23)00082-2. [PMID: 36906263 DOI: 10.1016/j.ajpath.2023.02.013] [Reference Citation Analysis]
|
| 2 |
Bellavite P, Ferraresi A, Isidoro C. Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines. Biomedicines 2023;11. [PMID: 36830987 DOI: 10.3390/biomedicines11020451] [Reference Citation Analysis]
|
| 3 |
Bernstein HG, Keilhoff G, Dobrowolny H, Steiner J. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - a critical overview. Rev Neurosci 2023;34:1-24. [PMID: 35771831 DOI: 10.1515/revneuro-2022-0026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Tsilioni I, Theoharides TC. Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells.. [DOI: 10.21203/rs.3.rs-2394904/v1] [Reference Citation Analysis]
|
| 5 |
Sahajpal NS, Hastie AR, Schieck M, Mondal AK, Felde M, van der Made CI, Chou JS, Randolph AG, Illig T, Zody MC, Brownstein CA, Beggs AH, Hoischen A, Chaubey A, Kolhe R; COVID19hostgenomesv Consortium. Genetic Predisposition to Neurological Complications in Patients with COVID-19. Biomolecules 2023;13. [PMID: 36671517 DOI: 10.3390/biom13010133] [Reference Citation Analysis]
|
| 6 |
Stefanou Ε, Karvelas N, Bennett S, Kole C. Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review. Curr Treat Options Neurol 2023;25:71-92. [PMID: 36950279 DOI: 10.1007/s11940-023-00747-6] [Reference Citation Analysis]
|
| 7 |
Fujimoto T, Erickson MA, Banks WA. Neurotropism and blood-brain barrier involvement in COVID-19. Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.1073815] [Reference Citation Analysis]
|
| 8 |
Devaux CA, Camoin-jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1042200] [Reference Citation Analysis]
|
| 9 |
Pelisek J, Reutersberg B, Greber UF, Zimmermann A. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. Clinical Science 2022;136:1571-1590. [DOI: 10.1042/cs20220235] [Reference Citation Analysis]
|
| 10 |
Hogberg HT, Lam A, Ohayon E, Shahbaz MA, Clerbaux L, Bal-price A, Coecke S, Concha R, De Bernardi F, Edrosa E, Hargreaves AJ, Kanninen KM, Munoz A, Pistollato F, Saravanan S, Garcia-reyero N, Wittwehr C, Sachana M. The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19. Cells 2022;11:3411. [DOI: 10.3390/cells11213411] [Reference Citation Analysis]
|
| 11 |
Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022;76:102608. [PMID: 35863101 DOI: 10.1016/j.conb.2022.102608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Yang J, Song H, Hao X. Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and without dementia. J Med Virol 2023;95:e28177. [PMID: 36168207 DOI: 10.1002/jmv.28177] [Reference Citation Analysis]
|
| 13 |
Wu G, Zhang M, Xie X, Zhu Y, Tang H, Zhu X, Liang Y, Chen T, Zhu K, Zhang D, Jiang S, Jiang Z, Ke S. A survey on the safety of the SARS-CoV-2 vaccine among a population with stroke risk in China. Front Med 2022;9. [DOI: 10.3389/fmed.2022.859682] [Reference Citation Analysis]
|
| 14 |
Omidian N, Mohammadi P, Sadeghalvad M, Mohammadi-Motlagh HR. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? Biomed Pharmacother 2022;154:113534. [PMID: 35994816 DOI: 10.1016/j.biopha.2022.113534] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 15 |
Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, Zhang Q, Li Y, Wan P, Wu J. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther 2022;7:218. [PMID: 35798726 DOI: 10.1038/s41392-022-01080-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 16 |
Zhang K, Wang K, Zhang C, Teng X, Li D, Chen M. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer 2022;22:687. [PMID: 35733175 DOI: 10.1186/s12885-022-09763-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Keep RF, Jones HC, Drewes LR. Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity. Fluids Barriers CNS 2022;19:48. [PMID: 35681151 DOI: 10.1186/s12987-022-00343-x] [Reference Citation Analysis]
|
| 18 |
Girolamo F, Errede M, Bizzoca A, Virgintino D, Ribatti D. Central Nervous System Pericytes Contribute to Health and Disease. Cells 2022;11:1707. [DOI: 10.3390/cells11101707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Nampoothiri M. The Nervous system, COVID-19 and Cerebrovascular complications: A strange riddle of the time. Trends Cardiovasc Med 2022:S1050-1738(22)00068-8. [PMID: 35561998 DOI: 10.1016/j.tcm.2022.05.001] [Reference Citation Analysis]
|
| 20 |
Gudowska-Sawczuk M, Mroczko B. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review. Int J Mol Sci 2022;23:5283. [PMID: 35563673 DOI: 10.3390/ijms23095283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Macdougall M, El-hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol 2022;13:871276. [DOI: 10.3389/fimmu.2022.871276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Nelson AR. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease. Front Aging Neurosci 2022;14:858429. [DOI: 10.3389/fnagi.2022.858429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Carmona-rivera C, Zhang Y, Dobbs K, Markowitz TE, Dalgard CL, Oler AJ, Claybaugh DR, Draper D, Truong M, Delmonte OM, Licciardi F, Ramenghi U, Crescenzio N, Imberti L, Sottini A, Quaresima V, Fiorini C, Discepolo V, Vecchio AL, Guarino A, Pierri L, Catzola A, Biondi A, Bonfanti P, Harlowe MCP, Espinosa Y, Astudillo C, Rey-jurado E, Vial C, de la Cruz J, Gonzalez R, Pinera C, Mays JW, Ng A, Platt A, Drolet B, Moon J, Cowen EW, Kenney H, Weber SE, Castagnoli R, Magliocco M, Stack MA, Montealegre G, Barron K, Hewitt SM, Arkin LM, Chertow DS, Su HC, Notarangelo LD, Kaplan MJ, NIH COVID Autopsy Consortium, COVID STORM Clinicians. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19.. [DOI: 10.1101/2022.02.24.22271475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Ihunwo AO, Perego J, Martino G, Vicenzi E, Panina-bordignon P. Neurogenesis and Viral Infection. Front Immunol 2022;13:826091. [DOI: 10.3389/fimmu.2022.826091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Tsvetanov KA, Spindler LRB, Stamatakis EA, Newcombe VF, Lupson VC, Chatfield DA, Manktelow AE, Outtrim JG, Elmer A, Kingston N, Bradley JR, Bullmore ET, Rowe JB, Menon DK, The Cambridge NeuroCOVID Group, The NIHR COVID-19 BioResource, The Cambridge NIHR Clinical Research Facility, The CITIID-NIHR BioResource COVID-19 Collaboration. Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study.. [DOI: 10.1101/2022.02.01.22270235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 27 |
Tsvetanov KA, Spindler LRB, Stamatakis EA, Newcombe VFJ, Lupson VC, Chatfield DA, Manktelow AE, Outtrim JG, Elmer A, Kingston N, Bradley JR, Bullmore ET, Rowe JB, Menon DK; Cambridge NeuroCOVID Group, NIHR COVID-19 BioResource, Cambridge NIHR Clinical Research Facility, CITIID-NIHR BioResource COVID-19 Collaboration. Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study. Neuroimage Clin 2022;36:103253. [PMID: 36451358 DOI: 10.1016/j.nicl.2022.103253] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
